GI CANCERS

Latest News

Phase 1b/2 Study of BXQ-350 in Metastatic Colorectal Cancer Completes Enrollment
Phase 1b/2 Study of BXQ-350 in Metastatic Colorectal Cancer Completes Enrollment

November 27th 2024

Enrollment has been completed for the phase 1b/2 ASIST study that is evaluating BXQ-350 in combination with standard-of-care treatments in patients with newly diagnosed metastatic colorectal cancer.

FDA Approves HER2 Test as Companion Diagnostic for Zanidatamab in Biliary Tract Cancer
FDA Approves HER2 Test as Companion Diagnostic for Zanidatamab in Biliary Tract Cancer

November 25th 2024

Updated Zanidatamab Data Shows Durable Response in Biliary Tract Cancer
Updated Zanidatamab Data Shows Durable Response in Biliary Tract Cancer

November 23rd 2024

FDA Approves Zanidatamab in HER2+ Biliary Tract Cancer
FDA Approves Zanidatamab in HER2+ Biliary Tract Cancer

November 21st 2024

Adding Bevacizumab Improves PFS, But Not OS, in Advanced Biliary Tract Cancer
Adding Bevacizumab Improves PFS, But Not OS, in Advanced Biliary Tract Cancer

November 6th 2024